A prospective single-centre observational series of omalizumab in paediatric chronic

An assessment of where endotype-directed prescribing now stands following two

A guideline-focused teaching lecture covering classification, diagnostic work-up and treat-to-target

An expert overview of pathomechanism and the emerging therapeutic pipeline,

An expert overview of pathomechanism and the emerging therapeutic pipeline,

SETTING THE SCENE JAK1 inhibition in AD has been validated